Home>People>Graduates

Annemarie Carlstedt

Germany
LGSA Member

Merlin dependent intra- and intercellular signaling network alterations in NF2 disease

Friedrich Schiller University Jena (FSU): Faculty of Biological Sciences
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI): Morrison Research Group

First Supervisor:

Helen Morrison (Leibniz Institute on Aging - Fritz Lipmann Institute (FLI))

Doctoral Disputation:

2021

Publications 2023:

  • Proteomic analysis of peripheral nerve myelin during murine aging.
    Helbing DL, Kirkpatrick JM, Reuter M, Bischoff J, Stockdale A, Carlstedt A, Cirri E, Bauer R, Morrison H
    Front Cell Neurosci 2023, 17, 1214003

    • Publications 2021:

    • Merlin dependent intra- and intercellular signaling network alterations in NF2 disease
      Carlstedt A
      Dissertation 2021, Jena, Germany

    Publications 2019:

    • The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.
      Cui* Y, Groth* S, Troutman S, Carlstedt A, Sperka T, Riecken LB, Kissil JL, Jin H, Morrison H
      Oncogene 2019, 38(36), 6370-81 * equal contribution
    • Preclinical Assessment of MEK1/2 Inhibitors for Neurofibromatosis Type 2-Associated Schwannomas Reveal Differences in Efficacy and Drug Resistance Development.
      Fuse MA, Dinh CT, Vitte J, Kirkpatrick J, Mindos T, Plati SK, Young JI, Huang J, Carlstedt A, Franco MC, Brnjos K, Nagamoto J, Petrilli A, Copik AJ, Soulakova JN, Bracho O, Yan D, Mittal R, Shen R, Telischi FF, Morrison H, Giovannini M, Liu XZ, Chang LS, Fernandez-Valle C
      Neuro-oncol 2019, 21(4), 486-97

    Publications 2018:

    • Inflammaging impairs peripheral nerve maintenance and regeneration.
      Büttner R, Schulz A, Reuter M, Akula AK, Mindos T, Carlstedt A, Riecken LB, Baader SL, Bauer R, Morrison H
      Aging Cell 2018, 17(6), e12833
    • Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells.
      Rauch A, Carlstedt A, Emmerich C, Mustafa AHM, Göder A, Knauer SK, Linnebacher M, Heinzel T, Krämer OH
      Oncotarget 2018, 9(45), 27835-50
    • Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.
      Synodos for NF2 Consortium, Allaway R, Angus SP, Beauchamp RL, Blakeley JO, Bott M, Burns SS, Carlstedt A, Chang LS, Chen X, Clapp DW, Desouza PA, Erdin S, Fernandez-Valle C, Guinney J, Gusella JF, Haggarty SJ, Johnson GL, La Rosa S, Morrison H, Petrilli AM, Plotkin SR, Pratap A, Ramesh V, Sciaky N, Stemmer-Rachamimov A, Stuhlmiller TJ, Talkowski ME, Welling DB, Yates CW, Zawistowski JS, Zhao WN
      PLoS One 2018, 13(6), e0197350